Rice  Doug net worth and biography

Rice Doug Biography and Net Worth

Mr. Rice became Chief Financial Officer of Orthofix in April 2015. He joined the Company as its Chief Accounting Officer in September 2014 and was named Interim CFO shortly thereafter. Prior to joining Orthofix, Mr. Rice served as the Chief Financial Officer of Vision Source, a national optometric network provider. He joined Vision Source from McAfee, a global antivirus software and computer security company, where he was Vice President Finance and Treasurer from 2007 until 2012, when McAfee was acquired by Intel Corporation. From 2000 to 2007, Mr. Rice was Senior Vice President and Corporate Controller of Concentra, Inc., a national healthcare service provider. He also worked for PricewaterhouseCoopers in various roles including Audit Manager. Mr. Rice is a Certified Public Accountant and holds an MBA and BBA, with honors, from Southern Methodist University.

What is Rice Doug's net worth?

The estimated net worth of Rice Doug is at least $1.48 million as of November 21st, 2023. Mr. Doug owns 102,200 shares of Orthofix Medical stock worth more than $1,483,944 as of March 29th. This net worth estimate does not reflect any other investments that Mr. Doug may own. Learn More about Rice Doug's net worth.

How do I contact Rice Doug?

The corporate mailing address for Mr. Doug and other Orthofix Medical executives is 3451 Plano Parkway, Lewisville TX, 75056. Orthofix Medical can also be reached via phone at (214) 937-2000 and via email at [email protected]. Learn More on Rice Doug's contact information.

Has Rice Doug been buying or selling shares of Orthofix Medical?

Rice Doug has not been actively trading shares of Orthofix Medical within the last three months. Most recently, on Friday, November 19th, Rice Doug bought 1,400 shares of Orthofix Medical stock. The stock was acquired at an average cost of $30.05 per share, with a total value of $42,070.00. Learn More on Rice Doug's trading history.

Who are Orthofix Medical's active insiders?

Orthofix Medical's insider roster includes Catherine Burzik (Director), Rice Doug (CFO), Kimberley Elting (Insider), Michael Paolucci (Director), and Jon Serbousek (CEO). Learn More on Orthofix Medical's active insiders.

Are insiders buying or selling shares of Orthofix Medical?

In the last year, Orthofix Medical insiders bought shares 1 times. They purchased a total of 7,500 shares worth more than $101,025.00. In the last year, insiders at the medical device company sold shares 2 times. They sold a total of 8,243 shares worth more than $156,617.00. The most recent insider tranaction occured on September, 14th when Director James F Hinrichs bought 7,500 shares worth more than $101,025.00. Insiders at Orthofix Medical own 4.7% of the company. Learn More about insider trades at Orthofix Medical.

Information on this page was last updated on 9/14/2023.

Rice Doug Insider Trading History at Orthofix Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/19/2021Buy1,400$30.05$42,070.00View SEC Filing Icon  
11/2/2018Sell6,057$61.25$370,991.2526,511View SEC Filing Icon  
10/11/2018Sell3,949$55.65$219,761.8532,368View SEC Filing Icon  
9/11/2017Sell7,353$49.46$363,679.3844,743View SEC Filing Icon  
See Full Table

Rice Doug Buying and Selling Activity at Orthofix Medical

This chart shows Rice Doug's buying and selling at Orthofix Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Orthofix Medical Company Overview

Orthofix Medical logo
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Read More

Today's Range

Now: $14.52
Low: $14.22
High: $14.76

50 Day Range

MA: $13.91
Low: $13.00
High: $14.62

2 Week Range

Now: $14.52
Low: $9.57
High: $21.60

Volume

248,060 shs

Average Volume

443,676 shs

Market Capitalization

$543.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03